20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1879L1 | P11 acetate | Integrin | |
P11 acetate is an integrin αvβ3-vitronectin interaction antagonist(IC50 = 2.74 nM). | |||
TP2326L | Oligopeptide P11-4 acetate(593266-60-5 free base) | Others | |
Oligopeptide P11-4 acetate is a peptide | |||
T34081 | Piromelatine | NEU-P-11,NEU-P 11,NEU-P11 | P2X Receptor , 5-HT Receptor , MT Receptor , Sodium Channel , TRP/TRPV Channel |
Piromelatine is an agonist of melatonin MT1/MT2 receptors, 5-HT1A and 5-HT1D, and an antagonist of 5-HT2B.Piromelatine has antinociceptive activity with inhibitory effects on P2X3, TRPV1, and Nav1.7 channels, and can be ... | |||
TP1879 | HSDVHK-NH2 | P11 | |
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic. | |||
T24586 | PAFAH1b2 | PAFAH-1-b-2,3-IN-P11,3INP11,3 IN P11,PAFAH 1 b 2 | |
PAFAH1b2 is a selective platelet-activating factor acetylhydrolases 1b2 and 1b3 inhibitor that acts by impairing cancer cell survival. | |||
T10922 | CYP11B2-IN-1 | P450 | |
CYP11B2-IN-1 is an effective and selective inhibitor of CYP11B2 with IC50s of 2.3 nM and 142 nM for CYP11B2 and CYP11B1. | |||
TP1947L | P110 TFA | Others | |
P110 TFA is a dynamin-related protein 1 (Drp1) inhibitor, inhibits Drp1 GTPase activity. | |||
T16422 | P110δ-IN-1 | PWT-143 | PI3K |
P110δ-IN-1 (PWT-143) is an effective and selective inhibitor of P110δ (IC50: 8.4 nM). | |||
T3969 | I-CBP112 | Epigenetic Reader Domain , Histone Acetyltransferase | |
I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains. | |||
T4472 | NMS-P118 | PARP | |
NMS-P118 is a potent, selective and orally available Inhibitor of PARP-1 for cancer therapy. | |||
T24437 | MCP110 | MCP-110,MCP 110 | Raf , Ras |
MCP110 is an inhibitor of the interaction of Ras with Raf-1 and can be used in studies about the treatment of human tumors. | |||
T7334 | NP118809 | 39-1B4 | Calcium Channel |
NP118809 (39-1B4) is a potent N-type calcium channel blocker(IC50 : 0.11 μM). | |||
T9596 | AP1189 acetate | Melanocortin Receptor | |
AP1189 acetate is a biased agonist at melanocortin 1 and melanocortin 3 receptors. | |||
T4247 | I-CBP112 hydrochloride | Epigenetic Reader Domain | |
I-CBP112 is a selective inhibitor of the bromodomain-containing transcription factors. I-CBP112 (1 mM) has little activity against other bromodomains. I-CBP112 targets the CBP/p300 bromodomains. I-CBP112 significantly re... | |||
T64249 | CYP11B1-IN-2 | ||
CYP11B1-IN-2 (compound 7aa) is a selective, orally active inhibitor of CYP11B1 that acts on human CYP11B1 (IC50: 9 nM) and rat CYP11B1 (IC50: 25 nM). CYP11B1-IN-2 can be used to study diseases caused by cortisol overload... | |||
T72397 | PARP11 inhibitor ITK7 | ITK7 | |
PARP11 Inhibitor ITK7 (ITK7) is a potent, selective inhibitor of PARP11, demonstrating significant efficacy with an IC50 value of 14 nM. It is primarily utilized in research focused on cellular localization. | |||
T78033 | SDP116 | ||
SDP116, a synthetic peptide derivative of the GPR116 Stachel sequence, exhibits ADGRF5 agonistic activity [1]. | |||
T68254 | WP1193 | ||
WP1193 is an inhibitor of the JAK2/STAT3 pathway. | |||
T38005 | P11149 | ||
P11149, a derivative of Galanthamine, acts as a competitive, orally active, and selective AChE inhibitor with the ability to weakly penetrate the blood-brain barrier (BBB). It demonstrates selective inhibition, exhibitin... | |||
T78204 | CYP11A1-IN-1 | ||
CYP11A1-IN-1 (compound 30) is a selective inhibitor of the enzyme CYP11A1, displaying an IC50 ranging from 201-2000 nM. It is applicable in the study of steroid receptor-mediated diseases, specifically targeting the andr... |